Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial
Ann S Knoop, Anne-Vibeke Lænkholm, Maj-Britt Jensen, Kirsten V Nielsen, Jørn Andersen, Dorte Nielsen, Bent Ejlertsen, Danish Breast Cancer Cooperative Group
Dive into the research topics of 'Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial'. Together they form a unique fingerprint.